The U.S. Market for Private Label OTC Healthcare Products

    Published: February 1, 2006 | Price: $3,000.00 – $6,000.00

    The private label over-the-counter (OTC) market has been gaining ground rapidly over the past five years. The private label sector has shed its image of being a ‘me-too’ version of national brands and worked toward offering quality and innovation at an economical price. With benefits for consumers, retailers, and manufacturers, private label healthcare should experience solid growth through the end of the decade. This report on the U.S. market for OTC private label products presents an in-depth analysis of the...
    The U.S. Market for Rx to OTC Switches, 6th Edition

    Published: January 11, 2013 | Price: $3,995.00 – $7,990.00

    The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription.   This report represents the six time that Kalorama Information has analyzed the market for drugs with switched ingredients in detail.  The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other...
    The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)

    Published: September 18, 2020 | Price: $5,500.00 – $11,000.00

    What is the Market for Urgent Care Centers?  What Services are they Selling?  Who is Selling Testing and Vaccine Products to Urgent Care? Kalorama's comprehensive report answers these questions, and more. With approximately 10,000 locations across the country, urgent care clinics (UCCs), are an increasingly important of the U.S. health care marketplace. They offer walk-in care and a range of services, expanded hours and limited wait times.  Urgent care centers are not new. There are many urgent care centers in operation...
    The U.S. Market for Urgent Care Centers, 2013 to 2017

    Published: October 6, 2014 | Price: $995.00 – $2,000.00

    The U.S. Market for Urgent Care Centers Urgent care centers are an increasingly important part of the provision of healthcare in the United States. The urgent care business model involves providing a complete grouping of services of primary care, along with injury treatment and imaging diagnostics. Convenient hours of operations are essential to the model of urgent care centers. Some urgent cares open as early as 7 a.m. or 8 a.m. and in turn close at 8-10 p.m. at night....
    The United States Market for In Vitro Diagnostic Tests: Forecasts to 2018

    Published: March 18, 2014 | Price: $1,995.00 – $3,990.00

    The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market.  Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments...
    The US Market for Rx to OTC Switches, Forecasts to 2019, 7th Edition

    Published: February 2, 2015 | Price: $1,995.00 – $3,995.00

    The US Market for Rx to OTC Switches Prescription products that are marketed as consumer products are known as Rx-to-OTC. They represent an important part of pharmaceutical strategy and a growing market. This report, The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. Patient-consumer awareness of health issues is driving the Rx-to-OTC market. Consumers are more prepared to take responsibility for their own health and are willing to purchase medicines over the...
    The World Anesthesia Drug Market

    Published: April 1, 2010 | Price: $3,995.00 – $7,990.00

    This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies in Anesthesia The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors. The report includes statistical...
    The World Anesthesia Drug Market (General, Local, Adjunctive)

    Published: March 22, 2012 | Price: $3,500.00 – $7,000.00

    This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia  Local Anesthesia  Adjunctive Therapies in Anesthesia  The report covers both currently marketed and late stage development anesthesia drugs.  For each of these segments the report contains: Products on the Market Products in Development Market Size and Forecast Market Share of Key Players Issues and Trends Revenues for each segment were generated using dollar and unit sales for each product.  Forecasted...
    The World Liquid Biopsy Market

    Published: May 30, 2019 | Price: $5,500.00 – $11,000.00

    Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid...
    The World Liquid Biopsy Market 2021

    Published: January 6, 2022 | Price: $5,000.00 – $10,000.00

    This report, The World Liquid Biopsy Market, 2021, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy The Market for EV and Exosome-based Liquid Biopsy The Market for Multi-Analyte-based Liquid Biopsy The Market for Other Liquid Biopsy Liquid Biopsy Market by Type...
    The World Market for Anti-Infectives, Volume II – Antibacterials

    Published: May 1, 2005 | Price: $2,500.00 – $5,000.00

    For the past 60 years, antibiotic drugs have changed bacterial infections from the life-threatening scourges they once were into eminently treatable conditions. However, the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to traditional agents. As a result, pharmaceutical companies are taking a second look at the antibiotic market, after more than two decades of relative complacency. In addition to the scientific and technical challenges of new antibiotic development, there are significant...
    The World Market for Anti-Infectives, Volume III – Antivirals

    Published: June 1, 2005 | Price: $2,500.00 – $5,000.00

    This volume of Kalorama Information’s World Market for Anti-Infectives series focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides an An overview Description of products on the market Description of products in development Market estimates and forecasts through 2009 Market segmentation by infection type Market segmentation by geographic region Market share of leading...
    The World Market for Biomarkers (Cardiac Markers [cTn, HscTn, Acute CK-MB/BNP, Others], Tumor Markers [PSA, CEA, CA 125, AFP, PSA Rapid, Others], Coagulation Markers [PT/INR, D-dimer], Infectious Disease Markers [by Disease], Immunological Disease Markers [Autoimmune/Allergy], Neurological Markers, C-Reactive Protein and Other Markers)

    Published: July 23, 2019 | Price: $5,000.00 – $10,000.00

    Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2014 to 2024, with 2019...
    The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

    Published: September 22, 2013 | Price: $2,995.00 – $6,000.00

    The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used by select worldwide generic companies in exploring the emerging area of biosimilars, the issues and trends that are shaping the marketplace, and the potential feasibility of providing biosimilars within the United States regulatory environment....
    The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays)

    Published: September 11, 2015 | Price: $1,995.00 – $3,995.00

    The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence.  The World Market for Cancer Diagnostics, 6th Edition., as well as relevant industry merger data provided by Kalorama Information,...